North America In Vitro Diagnostics Market Worth $39.67 Billion By 2030

January 2023 | Report Format: Electronic (PDF)

North America In Vitro Diagnostics Market Growth & Trends

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

key Request a free sample copy or view report summary: North America In Vitro Diagnostics Market Report

North America In Vitro Diagnostics Market Report Highlights

The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

North America In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the North America in vitro diagnostics market based on product, technology, application, end-use, test location, and country:

North America In Vitro Diagnostics Product Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

Instruments
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Reagents
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others

North America In Vitro Diagnostics Technology Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

Immunoassay
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Hematology
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Clinical Chemistry
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Molecular Diagnostics
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Coagulation
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Microbiology
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Others
- Product
  - Instruments
  - Reagents
  - Services
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others

North America In Vitro Diagnostics Application Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

Infectious Disease
- Disease
  - Methicillin-resistant Staphylococcus Aureus (MRSA)
  - Clostridium Difficile
  - Vancomycin-resistant Enterococci (VRE)
  - Carbapenem-resistant Bacteria
  - Flu
  - Respiratory Syncytial Virus (RSV)
  - Candida
  - Tuberculosis and Drug-resistant TBA
  - Meningitis
  - Gastrointestinal Panel Testing
  - Chlamydia
  - Gonorrhea
  - HIV
  - Hepatitis C
  - Hepatitis B
  - Other Infectious Diseases
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Diabetes
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Oncology
- Disease
  - Breast Cancer
  - Prostate Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Kidney Cancer
  - Liver Cancer
  - Blood Cancer
  - Lung Cancer
  - Other Cancer
- End-Use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Cardiology
- Disease
  - Coronary Heart Disease
  - Stroke
  - Peripheral Arterial Disease
  - Aortic Disease
  - Others
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Nephrology
- Disease
  - UTI
  - Kidney Disease
  - Diabetes
  - Others
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Autoimmune Diseases
- Disease
  - Rheumatoid Arthritis
  - Inflammatory Bowel Disease
  - Osteoporosis
  - Celiac Disease
  - Fibromyalgia
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Drug Testing
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others
Others
- End-use
  - Hospitals
  - Laboratories
  - Home Care
  - Clinic/Others
    - Physician Office
    - Pharmacy & Retail Clinics
    - Non-practice Clinics
    - Urgent Care Clinics
    - Others

North America In Vitro Diagnostics End-use Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

Hospitals
Laboratories
Home Care
Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others

North America In Vitro Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)

Point-of-Care
Others

North America In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America
- U.S.
- Canada

List of Key Players in the North America In Vitro Diagnostics Market

Abbott
bioMérieux SA
Bio-Rad Laboratories, Inc.
BD
Siemens Healthcare GmbH
QIAGEN
Quidel Corporation
F. Hoffmann-La Roche Ltd
Sysmex Corporation
Charles River Laboratories International, Inc.
Quest Diagnostics
Agilent Technologies, Inc.
Danaher

Request a Free Sample

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

We are committed towards customer satisfaction, and quality service.

Client Testimonials

"The quality of research they have done for us has been excellent..."

Brian Moore, VP, NICCA USA, Inc. testimonials More

ESOMAR Certified & Member

Privacy & Security Compliance

trustwave Validate

Payment & Banking Partners

authorize.net